Also trades as: LABS.TO (TSX) · $vol 0M
MEDIF OTC
MediPharm Labs Corp.
1W: +1.0%
1M: -3.6%
3M: +1.4%
YTD: +0.2%
1Y: -8.4%
3Y: -10.3%
5Y: -76.7%
$0.05
-0.00 (-3.40%)
Weekly Expected Move ±7.9%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$21.7M
52W Range0.04-0.076
Volume500
Avg Volume66,457
Beta0.99
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGreg Hunter
Employees127
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-01-08
Websitemedipharmlabs.com
151 John Street
Barrie, ON L4N 2L1
CA
Barrie, ON L4N 2L1
CA
705-719-7425
About MediPharm Labs Corp.
MediPharm Labs Corp. operates as a pharmaceutical firm specializing in the manufacturing and distribution of pharmaceutical-grade cannabis oils, concentrates, and advanced derivative products. The company's market presence spans Canada, Australia, Germany, and other international territories. Its comprehensive services encompass the formulation, processing, packaging, and distribution of sophisticated cannabinoid-based offerings. Additionally, MediPharm Labs provides GMP-compliant sourcing, packaging, and distribution services for cannabis flower. The organization was established in 2015 and is headquartered in Barrie, Canada.
Latest News
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
Here are the major earnings before the open Wednesday
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
MediPharm Labs reports Q4 results
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
Recent Insider Trades
No insider trades found